Back
Nektar Therapeutics Stock Price Chart
Washington Wants Your Money. Here's How to Opt Out.
Learn how to become your own bank. Watch the free training.
Sell
45
NKTR
Nektar Therapeutics
Last Price:
$43.36
Seasonality Move:
6.14%
7 Day Trial
ALL ACCESS PASS
$
7
BlackRock's $91B Secret
Learn how to access Native Markets before Coinbase. Watch the free training.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing buying pressure, which is a positive indicator for future bullish movement.
Nektar Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 43.77 | Sell |
| 20-day SMA: | 49.67 | Sell |
| 50-day SMA: | 55.41 | Sell |
| 200-day SMA: | 32.6 | Buy |
| 8-day EMA: | 44.09 | Sell |
| 20-day EMA: | 48.29 | Sell |
| 50-day EMA: | 51.6 | Sell |
| 200-day EMA: | 38.68 | Buy |
Nektar Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -4.04 | Sell |
| Relative Strength Index (14 RSI): | 35.41 | Sell |
| Chaikin Money Flow: | 543931 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.54 - 59.5) | Sell |
| Bollinger Bands (100): | (38.31 - 62.31) | Sell |
Nektar Therapeutics Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Nektar Therapeutics Stock
Is Nektar Therapeutics Stock a Buy?
-
Nektar Therapeutics share price is 42.28 while NKTR 8-day simple moving average is 43.77, which is a Sell signal.
-
The stock price of NKTR is 42.28 while Nektar Therapeutics 20-day SMA is 49.67, which makes it a Sell.
-
Nektar Therapeutics 50-day simple moving average is 55.41 while NKTR share price is 42.28, making it a Sell technically.
-
NKTR stock price is 42.28 and Nektar Therapeutics 200-day simple moving average is 32.60, creating a Buy signal.
NKTR Technical Analysis vs Fundamental Analysis
Sell
45
Nektar Therapeutics (NKTR)
is a Sell
Is Nektar Therapeutics a Buy or a Sell?
-
Nektar Therapeutics stock is rated a SellThe current Nektar Therapeutics [NKTR] share price is $42.28. The Score for NKTR is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
Nektar Therapeutics Stock Info
Market Cap:
731.5M
Price in USD:
42.28
Share Volume:
900K
Nektar Therapeutics 52-Week Range
52-Week High:
66.92
52-Week Low:
6.48
Sell
45
Nektar Therapeutics (NKTR)
is a Sell
Nektar Therapeutics Share Price Forecast
-
What is the Nektar Therapeutics stock price today?The Nektar Therapeutics stock price is 42.28 USD today.
-
Will NKTR stock go up or go down?Nektar Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Nektar Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Nektar Therapeutics is overvalued.
Is Nektar Therapeutics Stock a Buy?
-
Nektar Therapeutics share price is 42.28 while NKTR 8-day exponential moving average is 44.09, which is a Sell signal.
-
The stock price of NKTR is 42.28 while Nektar Therapeutics 20-day EMA is 48.29, which makes it a Sell.
-
Nektar Therapeutics 50-day exponential moving average is 51.60 while NKTR share price is 42.28, making it a Sell technically.
-
NKTR stock price is 42.28 and Nektar Therapeutics 200-day simple moving average is 38.68, creating a Buy signal.
Fundamental Analysis of Nektar Therapeutics
Is Nektar Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.54 per share, and a decrease next year of $2.39 per share.
Technical Analysis of Nektar Therapeutics
Should I short Nektar Therapeutics stock?
-
NKTR Moving Average Covergence Divergence (MACD) indicator is -4.04, suggesting Nektar Therapeutics is a Sell
-
Nektar Therapeutics Relative Strength Index (RSI) is 35.41, which suggest Nektar Therapeutics is oversold
-
The Bollinger Bands (25) for Nektar Therapeutics is (44.54 - 59.5), which suggest Nektar Therapeutics is a Sell
-
The Bollinger Bands (100) for Nektar Therapeutics is (38.31 - 62.31), which suggest Nektar Therapeutics is a Sell
* Nektar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.